The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy assessment of a novel pan-RAS inhibitor in KRAS-mutant and wild type colorectal 3D bioprinted organoid tumor tissue.
 
Parmanand Ahirwar
Employment - CerFlux, Inc.
 
Areesha A. Charania
Employment - CerFlux, Inc.
Research Funding - CerFlux, Inc.
 
Dana Zuaiter
Employment - CerFlux, Inc.
Research Funding - CerFlux, Inc.
 
Logan C. Eiler
Employment - CerFlux, Inc.
 
Alyssa Nizamuddin
Employment - CerFlux, Inc.
 
Chelsea L. Crawford
Employment - CerFlux, Inc.
 
Yulia Y. Maxuitenko
No Relationships to Disclose
 
Gary Piazza
Employment - ADT Pharmaceuticals
Leadership - ADT Pharmaceuticals
Stock and Other Ownership Interests - ADT Pharmaceuticals
Patents, Royalties, Other Intellectual Property - ADT Pharmaceuticals
 
Karim I. Budhwani
Employment - CerFlux, Inc.
Leadership - CerFlux, Inc.
Stock and Other Ownership Interests - CerFlux, Inc.
Research Funding - CerFlux, Inc.
Patents, Royalties, Other Intellectual Property - 3 US, 1 EU, 1 UK patents issued. 6 additional patents pending. Broadly related to microfluidics, bioengineering, lab-chip, tissue, or tumor models.
Other Relationship - American Cancer Society; BIO Alabama; Breast Cancer Research Foundation of Alabama; O'Neal Comprehensive Cancer Center